← Browse by Condition
Medical Condition
intracerebral hemorrhage
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 4, Phase 3
ClinicalMetric tracks all active clinical trials for intracerebral hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — intracerebral hemorrhage Clinical Trials
How many clinical trials are currently recruiting for intracerebral hemorrhage?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for intracerebral hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for intracerebral hemorrhage?
intracerebral hemorrhage research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a intracerebral hemorrhage clinical trial?
Eligibility criteria for intracerebral hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Phase 4 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06918964
Recruiting
Enrollment
186 pts
Location
China
Sponsor
Beijing Tiantan Hospital
NCT06728592
Recruiting
Enrollment
60 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
NCT05434065 Phase 2
Recruiting
Enrollment
60 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT06673602 Phase 4
Recruiting
Enrollment
200 pts
Location
China
Sponsor
Qinhuangdao Hospital of Tradit...
NCT06402968
Recruiting
Enrollment
1,018 pts
Location
United States
Sponsor
Zeenat Qureshi Stroke Institut...
NCT07302009
Recruiting
Enrollment
318 pts
Location
China
Sponsor
Yanyan Gong
NCT05504941
Recruiting
Enrollment
15 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...
NCT05095857 Phase 4
Recruiting
Enrollment
400 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
NCT04707105
Recruiting
Enrollment
856 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT03243175 Phase 3
Recruiting
Enrollment
300 pts
Location
France
Sponsor
University Hospital, Lille
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology